PHIA.AS : Summary for PHILIPS KON - Yahoo Finance

U.S. Markets closed

PHILIPS KON (PHIA.AS)


Amsterdam - Amsterdam Delayed Price. Currency in EUR
Add to watchlist
28.02+0.02 (+0.09%)
At close: 11:35 AM EST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close28.00
Open27.99
Bid23.00 x 8300
Ask23.34 x 17500
Day's Range27.67 - 28.09
52 Week Range20.77 - 28.09
Volume2,652,503
Avg. Volume3,030,684
Market Cap25.57B
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Philips Partners with NYMC to Boost Healthcare Portfolio
    Zacks2 days ago

    Philips Partners with NYMC to Boost Healthcare Portfolio

    Koninklijke Philips NV (PHG) recently strengthened its collaboration with premier academic institution, New York Medical College (NYMC), for co-creation of its digitally advanced oncology genomics solution, Philips IntelliSpace.

  • Is Manulife Financial Corporation (USA) (MFC) A Good Stock To Buy?
    Insider Monkey3 days ago

    Is Manulife Financial Corporation (USA) (MFC) A Good Stock To Buy?

    Does Manulife Financial Corporation (USA) (NYSE:MFC) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund sentiment towards the company. Hedge fund firms constantly search out bright intellectuals and highly-experienced employees and throw away millions of dollars on research activities, so it is no wonder why they tend to generate millions […]

  • Reuters3 days ago

    From smart toothbrushes to cancer, Philips bets big on software

    These days the average researcher at Philips (PHG.AS) is more likely to be a software developer than an product engineer, reflecting a transformation at the former Dutch conglomerate that its chief executive says will gather pace. "It's a huge shift," Frans van Houten told Reuters, noting that around 60 percent of the healthcare technology company's R&D staff are now focused on software. Philips has repositioned itself as a health business after spinning off lighting, which has freed up capacity for acquisitions such as last year's $1.2 billion purchase of blood vessel imaging firm Volcano.